Prior results with the drug in other surgical settings have been mixed ...

Please provide your email address to receive an email when new articles are posted on . Any bleeding event regardless of severity can adversely impact a patient. Factor XI and XIa inhibitors in ...

Concomitant use of SSRIs and OACs was associated with a 33% increased risk for major bleeding. Among patients with atrial fibrillation (AF), concomitant use of selective serotonin reuptake inhibitors ...

In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.

In the CKD population treated with oral anticoagulants for atrial fibrillation, major bleeding is more likely in male patients and those with congestive heart failure, vascular disease, and a history ...

A new guide offers recommendations for the nonsurgical management of major hemorrhage, which is a challenging clinical problem. Major hemorrhage is a significant cause of death and can occur in a ...

Two of three commonly prescribed non-vitamin K oral anticoagulants (NOACs)—dabigatran and apixaban—have similar rates of major bleeding compared with aspirin, a large systematic review and ...

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices MARLBOROUGH, Mass., Oct. 24, 2023 /PRNewswire/ -- Data ...

Concomitant use of selective serotonin reuptake inhibitors (SSRIs) and oral anticoagulants (OACs) in patients with atrial fibrillation was tied to an increased risk of major bleeding compared with OAC ...

Daily aspirin ups bleeding risk Daily low-dose aspirin use to prevent heart disease is associated with an increased risk of major gastrointestinal (GI) or cerebral bleeding. HealthDay News — Daily low ...

Please provide your email address to receive an email when new articles are posted on . A systematic review and meta-analysis of nine trials comparing non-vitamin K oral anticoagulants with low-dose ...